OTC · RTNXF
Renalytix Plc
$0.08$0.00 (0.0%)
Renalytix Plc’s quoted price sits in the lower half of its reported 52-week range, 87.52% below the high.
Loading market information…
OTC · VILGF · USD
Stock price
Quote as of Jun 9, 2023, 02:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Yourgene Health Plc is a molecular diagnostics firm specializing in the development, manufacturing, and commercialization of advanced genomic solutions, primarily for prenatal screening and diverse other applications across the UK, Europe, and globally. The company's in-vitro diagnostic (IVD) portfolio features key products such as the IONA Test, a non-invasive prenatal test (NIPT) for screening pregnant women for Down's, Edwards', and Patau's syndromes. Other diagnostics include Cystic Fibrosis Screening tests, Rapid Aneuploidy Analysis (a confirmatory diagnostic performed post-amniocentesis), and a Recurrent Pregnancy Loss PCR assay that identifies the six most common chromosomes linked to miscarriage. Additionally, it offers DPYD genotyping products. Beyond these, Yourgene Health provides Ranger, a technology platform facilitating sample size selection and enrichment. It also offers the Elucigene DPYD assay, a PCR test crucial for predicting patient response to chemotherapy, and the Clarigene SARS-CoV-2 CE-IVD, a PCR assay utilized for standard COVID-19 testing. The company further extends its offerings to clinical research organizations (CROs) through a comprehensive suite of genomic services. These include sample preparation and analysis tools, bioinformatics and software solutions, along with specialized services such as DNA, RNA/miRNA, and nucleonic extraction, quantification, genotyping, gene expression analysis, methylation studies, and microarray services. Established in 2000, the company, formerly known as Premaitha Health PLC until its rebranding in November 2018, is headquartered in Manchester, United Kingdom.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.08$0.00 (0.0%)
Renalytix Plc’s quoted price sits in the lower half of its reported 52-week range, 87.52% below the high.
$3.75+$0.01 (+0.27%)
PharmChem, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.78% below the high.
$0.39-$0.00 (-0.39%)
HS GovTech Solutions Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.22% below the high.
$0.15-$0.01 (-8.96%)
Vinergy Capital Inc.’s quoted price sits in the upper half of its reported 52-week range, 48.39% below the high.
$0.16-$0.03 (-15.36%)
TPCO Holding Corp.’s quoted price sits in the lower half of its reported 52-week range, 83.81% below the high.
€2.94-€0.11 (-3.61%)
Biofrontera AG’s quoted price sits in the lower half of its reported 52-week range, 43.24% below the high.
$2.74-$0.01 (-0.27%)
Organicell Regenerative Medicine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
$0.01-$0.04 (-76.0%)
Antisense Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 84.0% below the high.
